2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Cardiovascular

31.21 - Long-term prognostic value of coronary flow velocity reserve in renal transplant recipients

Presenter: Yasar, Caliskan, Istanbul, Turkey
Authors: Caliskan Y., Alpay N., Akagun T., Toz B., Kara E., Tufan F., Guz G., Polat N., Oflaz H., Turkmen A., Sever M.

LONG-TERM PROGNOSTIC VALUE OF CORONARY FLOW VELOCITY RESERVE IN RENAL TRANSPLANT RECIPIENTS

COMPLICATIONS - CARDIOVASCULAR

Y. Caliskan1, N. Alpay1, T. Akagun1, B. Toz1, E. Kara1, F. Tufan2, G. Guz3, N. Polat3, H. Oflaz3, A. Turkmen1, M.S. Sever1
1Department Of Internal Medicine, Division Of Nephrology, Istanbul University, Istanbul Faculty of Medicine, Istanbul/TURKEY, 2Department Of Internal Medicine, Division Of Geriatrics, Istanbul University, Istanbul Faculty of Medicine, Istanbul/TURKEY, 3Department Of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul/TURKEY

Body: Introduction: Cardiovascular diseases are still the major cause of death among renal transplant recipients. Coronary flow reserve (CFR) impairment is an early marker of subclinical coronary atherosclerosis and associated with endothelial dysfunction. In this prospective study, we aimed to investigate the long-term prognostic value of CFR and carotid intima media thickness (IMT) in renal transplant recipients without known coronary artery disease. Method: A total of 20 renal transplant recipients [13 male, 7 female, mean age: 33±9 (20-50) years] were included in this prospective follow up study. CFR recordings were performed by trans-thoracic Doppler echocardiography (TTDE). Carotid IMT was also measured in all patients. Serum levels of biochemical markers including serum glucose, BUN, creatinine, electrolytes, uric acid, calcium, phosphorus, total protein, albumin and total, LDL and HDL cholesterol levels were measured. Associations among these variables were analyzed. Results: During a follow up of three years, 2 patients died of malignancy and 3 of them lost to follow up. Only 1 patient, who underwent coronary angiography because of new-onset angina, had experience of cardiac event. The CFR value of this patient was 1.17 which means a severe CFR impairment. The baseline CFR and carotid IMT values of the patients were 1.77±0.48 and 0.67±0.15, respectively. After three years of follow up, there were no significant differences with regard to CFR (1.74±0.33, p=0.147) and IMT (0.67±0.09, p=0,376) values compared to baseline values. The differences in serum creatinine, total cholesterol and total protein levels after three years were also not significant. The CFR value at the third year of follow up, significantly correlated with age (r=-0.607, p=0.021), IMT at baseline (r=-0.739, p=0.004) and the third year (r=-0.541, p=0.046). In multivariate analysis, baseline carotid IMT (β=−0.562, p=0.05) was a significant independent predictor of CFR at the third year. Conclusion: Carotid IMT has a greater predictive value for impaired CFR in renal transplant recipients. Because of the small number of patients and cardiac events in this study, CFR was not found to be an independent predictor for future cardiovascular events in renal transplant recipients.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada